BATS:VIRS Pacer BioThreat Strategy ETF (VIRS) Price, Holdings, & News → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free VIRS Stock Alerts $35.60 -0.14 (-0.39%) (As of 05/30/2024 ET) Add Compare Share Share Today's Range$35.61▼$35.6150-Day Range$33.61▼$36.3252-Week Range N/AVolume42 shsAverage VolumeN/AMarket Capitalization$3.56 millionAssets Under Management$3.56 millionDividend Yield0.95%Net Expense Ratio0.70% Stock AnalysisStock AnalysisChartDividendHoldingsOwnershipRatingsStock AnalysisChartDividendHoldingsOwnershipRatings Get Pacer BioThreat Strategy ETF alerts: Email Address About Pacer BioThreat Strategy ETFThe Pacer BioThreat Strategy ETF (VIRS) is an exchange-traded fund that is based on the LifeSci BioThreat Strategy index. The fund tracks a market-cap weighted index of US companies whose products or services address biological threats to human health. VIRS was launched on Jun 24, 2020 and is managed by Pacer.Read More VIRS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIRS ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive VIRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pacer BioThreat Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerPacer Financial Fund NamePacer BioThreat Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:VIRS Inception Date6/24/2020 Fund ManagerBruce Kavanaugh, Michael Mack WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci BioThreat Strategy Index CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionNorth America Number of Holdings54 Fund Statistics Assets Under Management$3.56 million Average Daily Volume$0.00 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorPacer Advisors, Inc. CustodianU.S. Bank, N.A. DistributorPacer Financial, Inc. Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Miscellaneous Outstanding Shares100,000Beta0.85 Creation Unit50,000 Creation Fee$250.00 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Pacer BioThreat Strategy ETF ExpensesTypeVIRSTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.70%0.57%0.54%0.56%0.51%Other Expenses0.00%0.72%0.54%0.51%0.58%Total Expense0.70%0.72%0.70%0.68%0.70%Fee Waiver0.00%-0.76%-0.55%-0.34%-0.56%Net Expense0.70%0.59%0.60%0.63%0.58% Pacer BioThreat Strategy ETF (VIRS) Holdings & ExposureTop 10 VIRS HoldingsNVIDIA(NASDAQ:NVDA)Holding Weight: 8.27%Netflix(NASDAQ:NFLX)Holding Weight: 5.60%Walmart(NYSE:WMT)Holding Weight: 5.31%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 5.26%Amazon.com(NASDAQ:AMZN)Holding Weight: 5.19%Danaher(NYSE:DHR)Holding Weight: 5.08%Thermo Fisher Scientific(NYSE:TMO)Holding Weight: 5.08%Lowe's Companies(NYSE:LOW)Holding Weight: 4.47%Home Depot(NYSE:HD)Holding Weight: 4.37%Abbott Laboratories(NYSE:ABT)Holding Weight: 4.18%VIRS Sector ExposureVIRS Industry ExposureFull Holdings Details Similar ETFsFirst Trust Indxx Metaverse ETFNASDAQ:ARVRiShares Breakthrough Environmental Solutions ETFNASDAQ:ETECBarclays Women in Leadership ETNNYSEARCA:WILRiverNorth Patriot ETFBATS:FLDZVolshares Large Cap ETFNYSEARCA:VSLInstitutional OwnershipInternational Assets Investment Management LLCSold 324 shares on 4/11/2024Ownership: 14.358%View All Institutional Transactions VIRS ETF - Frequently Asked Questions How have VIRS shares performed in 2024? Pacer BioThreat Strategy ETF's stock was trading at $32.3154 at the beginning of the year. Since then, VIRS shares have increased by 10.2% and is now trading at $35.6050. View the best growth stocks for 2024 here. How often does Pacer BioThreat Strategy ETF pay dividends? What is the dividend yield for Pacer BioThreat Strategy ETF? Pacer BioThreat Strategy ETF declared a dividend on Wednesday, September 20th. Investors of record on Friday, September 22nd will be given a dividend of $0.0785 per share on Wednesday, September 27th. The ex-dividend date is Thursday, September 21st. Read our dividend analysis for VIRS. What does VIRS invest in? Pacer BioThreat Strategy ETF is a equity fund issued by Pacer Financial. VIRS focuses on theme investments and follows the LifeSci BioThreat Strategy Index. The fund's investments total to approximately $3.56 million assets under management. What stocks does Pacer BioThreat Strategy ETF hold? VIRS invests in 54 holdings. Some of the stocks in their portfolio include NVIDIA (NVDA), Netflix (NFLX), Walmart (WMT), Merck & Co., Inc. (MRK), Amazon.com (AMZN), Danaher (DHR), Thermo Fisher Scientific (TMO), Lowe's Companies (LOW), Home Depot (HD) and Abbott Laboratories (ABT). What is the management fee for Pacer BioThreat Strategy ETF? Pacer BioThreat Strategy ETF's management fee is 0.70% and has no other recorded expenses or fee waivers. The net expense ratio for VIRS is 0.70%. Who are Pacer BioThreat Strategy ETF's major shareholders? Pacer BioThreat Strategy ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include International Assets Investment Management LLC (14.36%). How do I buy shares of Pacer BioThreat Strategy ETF? Shares of VIRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (BATS:VIRS) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaElon Musk’s Final Masterpiece: “X-9840”Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacer BioThreat Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.